<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.openbell.ai/</loc>
    <lastmod>2026-09-25T22:39:47.759Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/support</loc>
    <lastmod>2026-09-25T22:39:47.759Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/privacy</loc>
    <lastmod>2026-09-25T22:39:47.759Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/terms</loc>
    <lastmod>2026-09-25T22:39:47.759Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/feed.json</loc>
    <lastmod>2026-09-25T22:39:47.759Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ABBV:1790373895484</loc>
    <lastmod>2026-09-25T22:04:55.484Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ABBV/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>U.S. FDA Approves Juvmo (Tavapadon) For Parkinson’s Disease In Adults On Sept 25, 2026</image:title>
      <image:caption>On September 25, 2026, the U.S. FDA approved Juvmo (Tavapadon) for the treatment of Parkinson&#39;s disease in adults. This approval is a significant milestone for AbbVie (ABBV), potentially impacting its market position in the neurological treatment sector. The approval may lead to increased revenue opportunities for the company as it expands its product offerings.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SLND:1790372370194</loc>
    <lastmod>2026-09-25T21:39:30.194Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SLND/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Southland Holdings Receives NYSE American Non-Compliance Notice</image:title>
      <image:caption>On September 23, 2026, Southland Holdings, Inc. (NYSE: SLND) received a non-compliance notice from NYSE American due to a stockholders’ deficit of $248.2 million and reported net losses in its last three fiscal years, violating listing standards. The company must submit a plan by October 23, 2026, to regain compliance by March 23, 2028, or face potential delisting. Despite the notice, the company&#39;s shares will continue to be traded on the NYSE American during this period.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AKAN:1790372140556</loc>
    <lastmod>2026-09-25T21:35:40.556Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AKAN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Akanda Determined That It Was No Longer Going To Pursue The Cultivation Of Cannabis Or Any Future Cannabis-Related Businesses; Going To Focus Its Business Efforts On Growth, Management Of Its First Towers &amp;amp; Fibers Corp. Subsidiary, Potentially Other Business Targets; Declined To Pay Next Option Payment Due Under Its Amended And Restated Option To Purchase Agreement With 1107385 B.C. LTD; Company’s Right To Acquire Or Use The BC Property Under The Option Agreement Has Been Terminated</image:title>
      <image:caption>On September 24, 2026, Akanda Corp. announced it will cease all cannabis cultivation and related business activities, shifting its focus to managing its First Towers &amp; Fibers Corp. subsidiary and exploring other business opportunities. The company declined to make the next payment under its Option Agreement with 1107385 B.C. LTD., resulting in the termination of its right to acquire a THC and CBD farming facility in British Columbia. Akanda has not cultivated any products from this property.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/LLY:1790370834308</loc>
    <lastmod>2026-09-25T21:13:54.308Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/LLY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Eli Lilly Receives FDA Approval For Olumiant In Pediatric Patients Aged 12 And Older With Severe Alopecia Areata</image:title>
      <image:caption>Eli Lilly and Company has received FDA approval for Olumiant (baricitinib) to treat pediatric patients aged 12 and older with severe alopecia areata (AA). This approval is based on data from the BRAVE-AA-PEDS study, which demonstrated significant scalp hair regrowth and improvements in eyebrows and eyelashes. The approval expands Olumiant&#39;s use, which was previously established for adults with rheumatoid arthritis and severe AA.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/GDHG:1790370556191</loc>
    <lastmod>2026-09-25T21:09:16.191Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GDHG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Golden Heaven Group&amp;#39;s Nanping Golden Carnival Culture Development Co. Acquires Amusement Park Assets For RMB139.9 Million; 50% Of Purchase Price Due Within Five Business Days; Remaining 50% Upon Asset Delivery</image:title>
      <image:caption>On September 25, 2026, Nanping Golden Carnival Culture Development Co., Ltd., a subsidiary of Golden Heaven Group Holdings Ltd., acquired amusement park assets from Guangxi Senguang Entertainment Investment Co., Ltd. for a total of RMB139.9 million. The purchase includes assets from Yixing Qinglongshan Happy World, Nanning Caribbean Water World, and Lishui Xingzhuang Park Children’s Amusement Park, with 50% of the payment due within five business days and the remaining 50% upon asset delivery.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/TDIC:1790370352282</loc>
    <lastmod>2026-09-25T21:05:52.282Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&amp;height=187</image:loc>
      <image:title>12 Communication Services Stocks Moving In Friday&amp;#39;s After-Market Session</image:title>
      <image:caption>In Friday&#39;s after-market session, Dreamland (NASDAQ: TDIC) shares surged 16.1% to $3.67, with a market cap of $6.7 million. Other notable gainers included NFT (AMEX: MI), which rose 11.45% to $2.53, and Motorsport Games (NASDAQ: MSGM), up 4.44% to $4.47, with a market value of $19.2 million. Conversely, Able View Global (NASDAQ: ABLV) saw a decline of 12.3% to $1.14, while Urban One (NASDAQ: UONEK) fell 10.19% to $3.35, with a market cap of $16.7 million.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ONCO:1790370351972</loc>
    <lastmod>2026-09-25T21:05:51.972Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&amp;height=187</image:loc>
      <image:title>12 Health Care Stocks Moving In Friday&amp;#39;s After-Market Session</image:title>
      <image:caption>In Friday&#39;s after-market session, Onconetix (NASDAQ: ONCO) saw its stock rise by 10.3% to $1.14, with a market value of $3.9 million. Other notable gainers included Bullfrog AI Holdings (NASDAQ: BFRG), which increased by 10.29% to $0.73, and Adicet Bio (NASDAQ: ACET), up 9.82% to $9.91, with market caps of $14.1 million and $77.4 million respectively. Conversely, NewGenIvf Group (NASDAQ: NIVF) experienced a decline of 7.7% to $0.52, bringing its market cap to $1.3 million.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MIMI:1790370351754</loc>
    <lastmod>2026-09-25T21:05:51.754Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&amp;height=187</image:loc>
      <image:title>12 Industrials Stocks Moving In Friday&amp;#39;s After-Market Session</image:title>
      <image:caption>In Friday&#39;s after-market session, Mint (NASDAQ:MIMI) shares rose 7.9% to $0.83, with a market value of $10.5 million. YYForce (NASDAQ:YFOR) shares increased by 6.8% to $1.57, while Armlogi Holding (NASDAQ:BTOC) saw a 6.76% rise to $0.28. Conversely, Galaxy Payroll Group (NASDAQ:GLXG) shares declined by 7.1% to $1.05, and Professional Diversity (NASDAQ:IPDN) stock decreased by 6.23% to $4.22.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MX:1790370351497</loc>
    <lastmod>2026-09-25T21:05:51.497Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&amp;height=187</image:loc>
      <image:title>12 Information Technology Stocks Moving In Friday&amp;#39;s After-Market Session</image:title>
      <image:caption>In Friday&#39;s after-market session, MagnaChip Semiconductor (NYSE: MX) saw a significant increase of 15.8%, reaching a stock price of $3.82, with a market capitalization of $116.1 million. Other notable gainers included Schmid Group (NASDAQ: SHMD) up 8.92% to $4.76, and UTime (NASDAQ: FXHO) rising 6.37% to $10.6. Conversely, WidePoint (AMEX: WYY) experienced a decline of 7.0%, dropping to $5.09, while Innoviz Technologies (NASDAQ: INVZ) fell 6.5% to $0.36.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CLDI:1790370201368</loc>
    <lastmod>2026-09-25T21:03:21.368Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CLDI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Calidi Biotherapeutics Receives NYSE American Non-Compliance Notice</image:title>
      <image:caption>Calidi Biotherapeutics, Inc. (NYSE: CLDI) received a non-compliance notice from NYSE American on September 21, 2026, due to insufficient stockholders&#39; equity, which must be at least $4 million. The company is required to submit a compliance plan by October 21, 2026, to regain compliance by March 21, 2028, or face potential delisting. The notice does not immediately affect the trading of its common stock, which will continue to trade under the symbol &#39;CLDI&#39; with a &#39;.BC&#39; designation for being below compliance. Management is currently reviewing options to address the deficiencies.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NCPL:1790370171002</loc>
    <lastmod>2026-09-25T21:02:51.002Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NCPL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Netcapital Receives Additional Nasdaq Non-Compliance Notice Due To Delinquent Q1 Form 10-Q And Fiscal 2026 Form 10-K Filings</image:title>
      <image:caption>Netcapital Inc. (NASDAQ: NCPL) received a notice from Nasdaq on September 21, 2026, for failing to file its Quarterly Report on Form 10-Q for the quarter ending July 31, 2026, and its Annual Report on Form 10-K for the fiscal year ending April 30, 2026, violating Nasdaq Listing Rule 5250(c)(1). The company has until October 23, 2026, to submit a compliance plan, which, if accepted, could grant an extension until February 9, 2027, to regain compliance. The notice does not currently affect the trading of NCPL stock, which continues to be listed on Nasdaq.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/FMAC:1790370143045</loc>
    <lastmod>2026-09-25T21:02:23.045Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/FMAC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Future Money Acquisition Corp. Receives Nasdaq Deficiency Notice Over Delayed July 31, 2026 Quarterly Form 10-Q Filing</image:title>
      <image:caption>Future Money Acquisition Corporation (NASDAQ: FMAC) received a deficiency notice from Nasdaq on September 22, 2026, due to its failure to file the Quarterly Report on Form 10-Q for the fiscal quarter ending July 31, 2026. The company has 60 days to submit a compliance plan, with the possibility of an extension of up to 180 days if accepted. Future Money Acquisition is actively working to file the report and regain compliance, but there is no guarantee of success within the required timeframe.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BSX:1790370100497</loc>
    <lastmod>2026-09-25T21:01:40.497Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BSX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>FDA Classifies Boston Scientific&amp;#39;s Recall Of Imager II Angiographic Catheters As Class I Due To Potential Catheter Tip Degradation And Detachment Risk</image:title>
      <image:caption>The FDA has classified Boston Scientific&#39;s recall of Imager II angiographic catheters as a Class I recall due to risks associated with potential catheter tip degradation and detachment. This classification indicates that the issue poses a significant risk of serious injury or death. The recall affects the safety and efficacy of the devices, which may impact the company&#39;s reputation and sales in the medical device market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/HIG:1790368947650</loc>
    <lastmod>2026-09-25T20:42:27.650Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HIG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Hartford Insurance Group Inks Reinsurance Commutation And Release Agreement With National Indemnity Company To Commute And Terminate Aggregate Excess Of Loss Reinsurance Agreement; Commutation Agreement Resolves Confidential Arbitration Dispute Under Reinsurance Agreement; Hartford Fire Insurance Receives $1.12B Cash Payment</image:title>
      <image:caption>On September 25, 2026, Hartford Fire Insurance Company received a cash payment of $1.12 billion from National Indemnity Company as part of a Reinsurance Commutation and Release Agreement, which terminated their existing Aggregate Excess of Loss Reinsurance Agreement. This agreement resolves a confidential arbitration dispute related to the reinsurance agreement that had been in place since December 31, 2016. Following this payment, both parties were released from liabilities and obligations under the agreement.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MVBF:1790368443801</loc>
    <lastmod>2026-09-25T20:34:03.801Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MVBF/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>DingoBlu Financial Announces Strategic Partnership With MVB Bank To Develop Mobile-First Financial Platform And Visa Debit Card Program</image:title>
      <image:caption>DingoBlu Financial, Inc. has announced a strategic partnership with MVB Bank, Inc. to develop a mobile-first financial platform and a Visa debit card program. This collaboration will leverage MVB Bank&#39;s regulated banking infrastructure to support DingoBlu&#39;s deposit products and banking services. DingoBlu aims to provide a streamlined mobile experience for managing everyday finances, with offerings including checking and savings accounts, digital account-management tools, and Visa debit card access.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MRK:1790368421974</loc>
    <lastmod>2026-09-25T20:33:41.974Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MRK/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Merck, Daiichi Sankyo Voluntarily Withdraw Biologics License Application Approval In U.S. For Ifinatamab Deruxtecan To Treat Small Cell Lung Cancer After Discussions With FDA</image:title>
      <image:caption>Merck and Daiichi Sankyo have voluntarily withdrawn their Biologics License Application (BLA) for ifinatamab deruxtecan (I-DXd) aimed at treating extensive-stage small cell lung cancer in the U.S. This decision follows discussions with the FDA, indicating that the data from the IDeate-Lung01 phase 2 trial did not meet the necessary requirements for accelerated approval. The accelerated approval pathway is designed for serious conditions with unmet medical needs.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/HIG:1790368214932</loc>
    <lastmod>2026-09-25T20:30:14.932Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HIG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Hartford Insurance Group Inks Reinsurance Commutation And Release Agreement With National Indemnity Company To Commute And Terminate Aggregate Excess Of Loss Reinsurance Agreement; Commutation Agreement Resolves Confidential Arbitration Dispute Under Reinsurance Agreement; Hartford Fire Insurance Receives $1.12B Cash Payment</image:title>
      <image:caption>Hartford Insurance Group has entered into a reinsurance commutation and release agreement with National Indemnity Company, which will terminate their aggregate excess of loss reinsurance agreement. This agreement resolves a confidential arbitration dispute related to the reinsurance agreement. As part of the settlement, Hartford Fire Insurance will receive a cash payment of $1.12 billion.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/HIG:1790368168343</loc>
    <lastmod>2026-09-25T20:29:28.343Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HIG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Hartford Insurance Group Inks Reinsurance Commutation And Release Agreement With National Indemnity Company To Commute And Terminate Aggregate Excess Of Loss Reinsurance Agreement; Commutation Agreement Resolves Confidential Arbitration Dispute Under Reinsurance Agreement; Hartford Fire Insurance Receives $1.12B Cash Payment</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ACET:1790367745819</loc>
    <lastmod>2026-09-25T20:22:25.819Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ACET/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Adicet Bio shares are trading higher after the company announced it will report clinical data from the Phase 1 study evaluating prulacabtagene leucel as a potential treatment for patients with systemic lupus erythematosus with or without lupus nephritis.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NTR:1790366878647</loc>
    <lastmod>2026-09-25T20:07:58.647Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Canpotex Invests C$500M In Neptune Bulk Terminals At Port Of Vancouver; Project To Support 400-500 Jobs With Majority Spending To Canadian Suppliers</image:title>
      <image:caption>Canpotex has announced a C$500 million investment in Neptune Bulk Terminals located at the Port of Vancouver. This project is expected to create between 400 to 500 jobs and will primarily source spending from Canadian suppliers. The investment underscores Canpotex&#39;s commitment to enhancing its operational capabilities in the region.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AMD:1790366525409</loc>
    <lastmod>2026-09-25T20:02:05.409Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/25/Shanghai-china-nov-22nd-2025-Amd-Company.jpg?width=250&amp;height=187</image:loc>
      <image:title>AMD Hits $1 Trillion, Muse Spooks Subscription Stocks: This Week on Wall Street</image:title>
      <image:caption>Advanced Micro Devices Inc. (AMD) achieved a market capitalization of over $1 trillion for the first time, with shares rising as much as 10% during the week, marking a nearly tripling in stock value since the beginning of the year. This surge was driven by increased demand for AI chips, widening the performance gap with Nvidia Corp. to over 160 percentage points. Meanwhile, the broader market faced challenges as Treasury yields spiked, with the 10-year yield reaching 5.2%, the highest since 2007.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ACET:1790366497900</loc>
    <lastmod>2026-09-25T20:01:37.900Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ACET/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Adicet Bio To Report Clinical Data From Phase 1 Study Evaluating Prulacabtagene Leucel As Potential Treatment For Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis On September 28</image:title>
      <image:caption>Adicet Bio, Inc. (NASDAQ: ACET) will report clinical data from its Phase 1 study on prulacabtagene leucel (prula-cel) as a potential treatment for systemic lupus erythematosus, including cases with or without lupus nephritis, on September 28, 2026. The company will also host a webcast presentation at 8:00am ET to discuss the results following the announcement.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/HUBC:1790366459258</loc>
    <lastmod>2026-09-25T20:00:59.258Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HUBC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>HUB Cyber Security Receives Nasdaq Noncompliance Notice</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/DAL:1790365717272</loc>
    <lastmod>2026-09-25T19:48:37.272Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/25/Delta-Air-Lines-Jet-Overturns-At-Toronto.jpg?width=250&amp;height=187</image:loc>
      <image:title>Delta Air Lines Stock Rises Friday: What&amp;#39;s Going On?</image:title>
      <image:caption>Delta Air Lines Inc. (NYSE: DAL) shares rose 2.78% to $85.06 on Friday, driven by a broader rally in the aviation sector following a diplomatic breakthrough in the Middle East that led to a decline in global crude oil and jet fuel prices. The easing of geopolitical risks has reduced energy costs, which are significant for airlines, enhancing profitability expectations as the fourth-quarter holiday travel season approaches. This favorable energy landscape may alleviate investor concerns regarding domestic capacity oversupply and margin compression.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/TT:1790365640706</loc>
    <lastmod>2026-09-25T19:47:20.706Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Trane Technologies shares are trading higher after Wells Fargo initiated coverage on the stock with an Overweight rating and announced a $536 price target.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/TSLA:1790365381208</loc>
    <lastmod>2026-09-25T19:43:01.208Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/25/Tesla-Optimus-Futuristic-Humanoid-Autono.jpg?width=250&amp;height=187</image:loc>
      <image:title>Exclusive: Tesla Optimus Commercialization Next Year Is ‘Very Realistic,’ Faraday Chairman Says</image:title>
      <image:caption>Faraday Future&#39;s Global Executive Chairman Jerry Wang stated that Tesla could realistically commercialize its Optimus humanoid robot by 2027, with software and training being the primary challenges. Faraday has already delivered over 500 robots this year and anticipates that humanoid robots could become common purchases for businesses and households within three to five years, potentially costing less than $20,000. Wang emphasized the importance of real-world data for robot training, indicating that the hardware is advanced but software development lags significantly.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/EQPT:1790365347616</loc>
    <lastmod>2026-09-25T19:42:27.616Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/EQPT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>EquipmentShare.com Refutes Recent Blue Orca Capital Report</image:title>
      <image:caption>EquipmentShare.com Inc (Nasdaq: EQPT) has issued a statement refuting a report by Blue Orca Capital, which it claims mischaracterizes its business model and financial statements. The company emphasizes that it adheres to U.S. GAAP and SEC disclosure requirements, with its financials audited by a Big 4 firm. EquipmentShare asserts that its operational performance and growth strategy remain strong, aiming to expand its presence in the construction technology and rental markets.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AAL:1790364972007</loc>
    <lastmod>2026-09-25T19:36:12.007Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/25/Phoenix--Az---December-7--2019-Photo-Of-.jpg?width=250&amp;height=187</image:loc>
      <image:title>American Airlines Stock Climbs Friday: What&amp;#39;s Happening?</image:title>
      <image:caption>American Airlines Group Inc. (NASDAQ: AAL) shares rose 3.52% to $13.82 on Friday, driven by a de-escalation in Middle East geopolitical tensions that led to a decline in global crude oil and jet fuel prices. The announcement from Iran regarding a plan to reopen the Strait of Hormuz has alleviated geopolitical risks, benefiting the airline industry by reducing fuel costs, which are a significant operating expense. This decrease in jet fuel prices is expected to improve American Airlines&#39; margin expectations as it approaches the busy fourth-quarter holiday travel season.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BTCUSD:1790364631830</loc>
    <lastmod>2026-09-25T19:30:31.830Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/25/Bitcoin-Btc-Cryptocurrency-Coin-With-Alt.jpg?width=250&amp;height=187</image:loc>
      <image:title>Bitcoin Slips Below $84,000 as Ethereum Holds $2,600, XRP and Dogecoin Rise on Rate-Hike Fears</image:title>
      <image:caption>Bitcoin (BTC) has fallen to $83,783.63, slipping below the $84,000 mark amid concerns over interest-rate hikes. Ethereum (ETH) is holding at $2,686.78, while XRP and Dogecoin have seen increases. In the past 24 hours, 79,553 traders were liquidated, totaling $278.63 million, and there were net inflows of $190.7 million into spot Bitcoin ETFs and $66.01 million into spot Ethereum ETFs.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/PLTR:1790364532196</loc>
    <lastmod>2026-09-25T19:28:52.196Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/25/Peter-Thiel-Says-Popes-AI-Push-Could-Ben.jpg?width=250&amp;height=187</image:loc>
      <image:title>Peter Thiel: Palantir Sales to US Corporations Accelerated &amp;#39;Tremendously&amp;#39; As Europe Falls Behind in AI</image:title>
      <image:caption>Palantir Technologies Inc. reported a 55% year-over-year increase in U.S. commercial revenue, reaching $159 million in Q2 2024, with a notable 83% rise in U.S. commercial customer count. Co-founder Peter Thiel highlighted the acceleration of sales to U.S. corporations as they adapt to artificial intelligence, contrasting this with Europe&#39;s slower adoption. Thiel emphasized the need for Europe to enhance its economy and compete in AI, as recent IMF data indicates a significant lag in AI adoption compared to the U.S.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/PLTR:1790364492885</loc>
    <lastmod>2026-09-25T19:28:12.885Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PLTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Peter Thiel: Palantir Sales to US Corporations Accelerated &amp;#39;Tremendously&amp;#39; As Europe Falls Behind in AI</image:title>
      <image:caption>Palantir Technologies Inc. reported a 55% year-over-year increase in U.S. commercial revenue, reaching $159 million in Q2 2024, with a notable 83% rise in total U.S. commercial customer count. Co-founder Peter Thiel emphasized that U.S. companies are rapidly adopting AI, contrasting this with Europe&#39;s slower pace, which he described as &#39;extremely far behind.&#39; Thiel&#39;s remarks align with recent IMF warnings about Europe&#39;s lag in AI adoption compared to the U.S.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/DOW:1790364429984</loc>
    <lastmod>2026-09-25T19:27:09.984Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/25/Dow-Chemical.jpg?width=250&amp;height=187</image:loc>
      <image:title>Dow Stock Drops Following UBS Price Target Cut</image:title>
      <image:caption>Dow Inc. (NYSE: DOW) shares fell 2.66% to $27.80 following a price target reduction by UBS analyst Joshua Spector, who lowered the 12-month target from $32 to $30 while maintaining a Neutral rating. This adjustment reflects ongoing margin pressures in the global commodity chemicals sector, driven by slow industrial demand recovery and elevated raw material costs. The chemicals sector is particularly affected by weak industrial activity in Europe and insufficient economic stimulus from China, impacting pricing power and EBITDA estimates.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/QCOM:1790364400607</loc>
    <lastmod>2026-09-25T19:26:40.607Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/QCOM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Shares of semiconductor companies are trading higher after the Anthropic-Akamai deal demonstrated industry demand. Also, Meta&amp;#39;s Muse AI agent strengthens the case for continued spending on CPUs, GPUs and AI infrastructure.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BCBP:1790363695035</loc>
    <lastmod>2026-09-25T19:14:55.035Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BCBP/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>BCB Bancorp Subsidiary BCB Community Bank Agrees tO Sell $205.3M In Problem Loans</image:title>
      <image:caption>BCB Bancorp&#39;s subsidiary, BCB Community Bank, has agreed to sell several portfolios of problem loans totaling approximately $205.3 million, with an estimated pre-tax loss of $43.3 million expected to be recorded in Q3 2026. The loan portfolios include commercial and multifamily real estate loans, commercial and industrial loans, and construction loans. Closing has been completed for five of the six transactions, with the final one anticipated to close by the end of Q3 2026. Hilltop Securities Inc. acted as financial advisor for the transactions.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/TSEM:1790363536232</loc>
    <lastmod>2026-09-25T19:12:16.232Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TSEM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Tower Semiconductor shares are trading higher after Mizuho initiated coverage on the stock with an Outperform rating and announced a $300 price target.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NGG:1790363320329</loc>
    <lastmod>2026-09-25T19:08:40.329Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NGG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>National Grid Selected For DOE Funding To Deploy Advanced Technology Across New England Transmission Network</image:title>
      <image:caption>National Grid has been selected for funding from the Department of Energy (DOE) to implement advanced technology across its transmission network in New England. This initiative aims to enhance the efficiency and reliability of electricity delivery in the region. The financial details of the funding have not been disclosed, but the project is expected to have a significant impact on the company&#39;s operations and the local energy market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/REBN:1790363218774</loc>
    <lastmod>2026-09-25T19:06:58.774Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/REBN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Why Is Reborn Coffee Stock Gaining Friday?</image:title>
      <image:caption>Reborn Coffee Inc. (NASDAQ: REBN) stock rose 9.73% to $1.24 after the company signed a strategic memorandum of understanding with Visvita to enhance its global franchise supply chain. The partnership aims to leverage Visvita&#39;s established beverage supplier network and logistics to support franchise expansion and launch a co-branded ready-to-drink beverage line. Although the memorandum is nonbinding and definitive agreements are yet to be negotiated, the collaboration is expected to facilitate store growth in North America and Latin America. Reborn Coffee has a market capitalization of nearly $10 million and operates 10 retail locations.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/INCY:1790362552268</loc>
    <lastmod>2026-09-25T18:55:52.268Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/INCY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>FDA Approves Atebrioz (Zilurgisertib) For Fibrodysplasia Ossificans Progressiva In Adults &amp;amp; Pediatric Patients 12+ Years; Atebrioz Recommended Dosage 100mg Once Daily</image:title>
      <image:caption>The FDA has approved Atebrioz (Zilurgisertib) for the treatment of Fibrodysplasia Ossificans Progressiva in adults and pediatric patients aged 12 years and older. The recommended dosage for Atebrioz is 100mg once daily. This marks a significant advancement in treatment options for this rare condition, potentially impacting the stock performance of Incyte Corporation (ticker: INCY).</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/REBN:1790362513842</loc>
    <lastmod>2026-09-25T18:55:13.842Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/25/Investors-Analyze-The-Data-Stock-Market-.jpg?width=250&amp;height=187</image:loc>
      <image:title>Why Is Reborn Coffee Stock Gaining Friday?</image:title>
      <image:caption>Reborn Coffee Inc. (NASDAQ: REBN) stock rose 9.73% to $1.24 following the announcement of a strategic memorandum of understanding with Visvita to enhance its global franchise supply chain. The partnership aims to leverage Visvita&#39;s established beverage supplier network and logistics to support Reborn Coffee&#39;s franchise expansion and the launch of a co-branded ready-to-drink beverage line. Currently, Reborn Coffee has a market capitalization of nearly $10 million and operates 10 retail locations, with a 50.20% decline in stock value over the past year.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/INCY:1790362428234</loc>
    <lastmod>2026-09-25T18:53:48.234Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/INCY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>FDA Approves Atebrioz (Zilurgisertib) For Fibrodysplasia Ossificans Progressiva In Adults &amp;amp; Pediatric Patients 12+ Years; Atebrioz Recommended Dosage 100mg Once Daily</image:title>
      <image:caption>The FDA has approved Atebrioz (Zilurgisertib) for the treatment of Fibrodysplasia Ossificans Progressiva in both adults and pediatric patients aged 12 years and older. The recommended dosage for this medication is 100mg once daily. This approval marks the third treatment option available for this rare condition, potentially impacting the market for INCY&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NIVF:1790362085608</loc>
    <lastmod>2026-09-25T18:48:05.608Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NIVF/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>NewGenIvf Group Shares Halted On Circuit Breaker To The Upside, Stock Now Up 66.54%</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MMM:1790362021751</loc>
    <lastmod>2026-09-25T18:47:01.751Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/25/Copenhagen--Denmark---August-3--2019-3m-.jpg?width=250&amp;height=187</image:loc>
      <image:title>This 3M Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday</image:title>
      <image:caption>Bernstein analyst Varun Govindaraj upgraded 3M Co (NYSE: MMM) from Underperform to Market Perform, raising the price target from $145 to $171. 3M shares closed at $167.52 on Thursday. This upgrade is part of a broader trend, as several companies received analyst upgrades, indicating a positive shift in market sentiment.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NKE:1790361845457</loc>
    <lastmod>2026-09-25T18:44:05.457Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/25/Perak--Malaysia---February-18--2018---Ni.jpg?width=250&amp;height=187</image:loc>
      <image:title>This Nike Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday</image:title>
      <image:caption>B of A Securities analyst Lorraine Hutchinson downgraded Nike Inc (NYSE: NKE) from Neutral to Underperform, reducing the price target from $47 to $30, while Nike&#39;s stock closed at $35.99 on Thursday. This downgrade is part of a broader trend, as analysts have also downgraded several other companies, including Comcast and Twilio, indicating a cautious outlook in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SNX:1790361682887</loc>
    <lastmod>2026-09-25T18:41:22.887Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/25/Analyst-Works-On-Personal-Computer-Showi.jpg?width=250&amp;height=187</image:loc>
      <image:title>TD Synnex Analysts Boost Their Forecasts After Q3 Results</image:title>
      <image:caption>TD SYNNEX Corp (NYSE: SNX) reported a fiscal Q3 2026 adjusted EPS of $5.68, a 59% increase year-over-year, surpassing estimates of $4.70. Revenue rose 37.7% to $21.56 billion, exceeding the $18.91 billion forecast. For Q4, the company anticipates adjusted EPS between $5.65 and $6.15 and revenue of $21.8 billion to $22.6 billion, both above analyst expectations. Following the results, analysts from Morgan Stanley and UBS raised their price targets to $359 and $379, respectively, while shares increased by 1.1% to $262.39.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/STEM:1790361599896</loc>
    <lastmod>2026-09-25T18:39:59.896Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/STEM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Stem shares are trading higher after UBS upgraded the stock from Neutral to Buy rating and maintained the price target at $7.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MRLN:1790361249763</loc>
    <lastmod>2026-09-25T18:34:09.763Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MRLN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Merlin shares are trading higher after Canaccord Genuity initiated coverage on the stock with a Buy rating and announced a $7.5 price target.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MBRX:1790361094451</loc>
    <lastmod>2026-09-25T18:31:34.451Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MBRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Moleculin Biotech shares are trading higher after the company announced new preclinical data indicating that the antitumor activity of its lead drug candidate, Annamycin, in pancreatic cancer is partially mediated by CD8+ T cell cytotoxicity.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/DAL:1790361038115</loc>
    <lastmod>2026-09-25T18:30:38.115Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/DAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Shares of airline companies are trading higher as oil prices retreat after Iran&amp;#39;s Foreign Minister confirmed that Iran has submitted to the U.S. a seven-day plan to reopen the Strait of Hormuz and start discussions on Iran&amp;#39;s nuclear program.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/PYPL:1790360913595</loc>
    <lastmod>2026-09-25T18:28:33.595Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/25/London--Uk---August-2021-Paypal-Finance-.jpg?width=250&amp;height=187</image:loc>
      <image:title>Why Is PayPal Stock Surging on Friday?</image:title>
      <image:caption>PayPal Holdings Inc. (NASDAQ: PYPL) stock surged 4.80% to $55.13 on Friday amid renewed acquisition rumors and a significant partnership in artificial intelligence. Reports indicate that a West Coast technology company is considering an all-stock takeover, although PayPal&#39;s board prefers an all-cash transaction. Additionally, Great Hill Capital&#39;s Chairman suggested that Meta Platforms Inc. could acquire PayPal for $90 billion, which would be accretive and enhance ad revenue capabilities. The stock is currently trading above its 20-day and 100-day simple moving averages, indicating a mixed technical outlook.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SPY:1790360773594</loc>
    <lastmod>2026-09-25T18:26:13.594Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Fed&amp;#39;s Hammack Says Likely Underlying Inflation Is Above Target</image:title>
      <image:caption>Federal Reserve official Hammack indicated that the underlying inflation rate is likely above the Fed&#39;s target level. This statement may influence market expectations regarding future monetary policy and interest rate adjustments. The comments come amidst ongoing discussions about inflationary pressures in the economy.</image:caption>
    </image:image>
  </url>
</urlset>